Gilenya

News

Novartis facing Gilenya generics again as Supreme Court lift...

Novartis' hopes that the Supreme Court would protect its big-selling multiple sclerosis drug Gilenya from generic competition have been dashed.

News

Supreme court throws Novartis a lifeline for Gilenya defense

In a dramatic change in fortunes, Novartis has won a major victory in its bid to defend oral multiple sclerosis therapy Gilenya from early generic competition in the US.

News

Novartis knocked back again in bid to block Gilenya generics...

Novartis is running out of options in its bid to defend oral muscular sclerosis therapy Gilenya from early generic competition in the US.

News

Novartis blocks generic to MS blockbuster Gilenya in US pate...

Novartis has blocked an attempt by Chinese drugmaker HEC Pharma to launch a generic version of its big-selling multiple sclerosis drug Gilenya in the US for almost six years.

Novartis facing Gilenya generics again as Supreme Court lift...

Supreme court throws Novartis a lifeline for Gilenya defense

Novartis knocked back again in bid to block Gilenya generics...

Novartis blocks generic to MS blockbuster Gilenya in US pate...

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Gilenya

Editor's Picks